Navigation Links
PTC Therapeutics Appoints Mark Rothera As Chief Commercial Officer
Date:4/23/2013

SOUTH PLAINFIELD, N.J., April 23, 2013 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the appointment of Mark A. Rothera as Chief Commercial Officer, reporting to Stuart W. Peltz , Ph.D., CEO of PTC Therapeutics. Mr. Rothera will be responsible for global commercial functions supporting PTC's pipeline, including the investigational new drug ataluren.

(Logo: http://photos.prnewswire.com/prnh/20010919/PTCLOGO )

"It is an exciting opportunity to join PTC," stated Mr. Rothera. "Ataluren is in late-stage clinical development for patients with nonsense mutation Duchenne muscular dystrophy and cystic fibrosis. Both indications have no treatment options targeting the underlying cause of the disorder. I look forward to applying my experience in rare diseases to build a commercial function at PTC dedicated to serving patients around the world."

A veteran of the orphan drug arena, Mr. Rothera has spent 15 of his 23 years in the biopharmaceutical industry bringing new therapies to patients with rare diseases. Mr. Rothera served previously as Global President of Aegerion Pharmaceuticals Inc. where he was responsible for global commercial operations, manufacturing, and supply chain. Previously Mr. Rothera was Vice President and General Manager for the commercial operations of Shire Human Genetic Therapies in Europe, the Middle East & Africa, where he was instrumental in leading growth through geographic expansion and the successful launches of three new therapies for rare diseases across 40 countries. Prior to Shire, Mr. Rothera held global strategic and operational marketing and sales roles with the French and UK operations of Glaxo Wellcome. Mr. Rothera's previous roles included Marketing Director,
'/>"/>

SOURCE PTC Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
2. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
3. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
4. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
5. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
6. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
7. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
8. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
9. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
10. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
11. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ) has announced the addition ... Analysis, Size, Share, Growth, Trends And Forecast, 2013 - ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Dental ... order to treat dental impairments, for tooth restoration and ...
(Date:1/15/2014)...  Novation, the leading health care supply chain expertise, analytics ... (VAR) national contracts that expand its portfolio to provide ... costs. These include manufacturer product and service agreements, as ... ongoing IT consulting support. New Novation ...
(Date:1/15/2014)... January 15, 2014 Shire plc (LSE: SHP, NASDAQ: ... of Fair Trading (OFT) approval condition to the announced tender offer ...   As a result of the waiver, the transaction ... complete the tender offer on January 24, 2014 following the currently ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3
... Everist Genomics, a rapidly growing personalized medicine company ... today that it has successfully completed acquisition of ... developer of the AngioDefender™ diagnostic device for assessing ... biomarker of early-stage atherosclerosis and CVD; it is ...
... 31, 2011 Baxano, Inc., a Silicon Valley based ... for spinal decompression surgery, announces a rapid expansion of ... its products. This continued expansion in ... new and existing accounts throughout the U.S. while providing ...
Cached Medicine Technology:Everist Genomics Announces Acquisition of Angiologix, Inc. 2Everist Genomics Announces Acquisition of Angiologix, Inc. 3Everist Genomics Announces Acquisition of Angiologix, Inc. 4Everist Genomics Announces Acquisition of Angiologix, Inc. 5Baxano Rapidly Expands Sales Force to Support Robust Demand for the iO-Flex® System 2
(Date:4/18/2014)... have made a brain-related discovery that could revolutionize ... This discovery opens up the possibility that environmental ... specific brain activity that the researchers have identified ... Journal of Neuroscience has just published a ... associate professor of psychology and his doctoral student ...
(Date:4/18/2014)... to potential new treatments for breaking the cycle of ... or scarring, is a hallmark of the disease, and ... to serious organ damage and, in some cases, death. ... findings made by Swati Bhattacharyya, PhD, research assistant professor ... protein plays in promoting fibrosis. , "Our results ...
(Date:4/17/2014)... have identified the first genetic variant specifically associated ... accounting for around 10-15 per cent of all ... of the breast cancer sub-type, called invasive lobular ... causes of this particular kind of breast cancer, ... research, published today (Thursday) in the journal ...
(Date:4/17/2014)... According to a study published today in PLOS ... world where malaria is common can mount an immune ... them to avoid repeated bouts of high fever and ... in their bloodstream. The findings may help researchers develop ... by the malaria parasite. , Each year, approximately 200 ...
(Date:4/17/2014)... Two recent papers by a University of Colorado ... scientists develop treatments or vaccines for Dengue fever, ... other disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, ... the School of Medicine and an early career ... colleagues recently published articles in the scholarly journals ...
Breaking Medicine News(10 mins):Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:CU researchers discover target for treating dengue fever 2
... Reporter , TUESDAY, April 3 (HealthDay News) -- Several Rhode ... of sharp wire bristles that made their way from barbecue ... which came from the metallic brushes used to clean grills, ... patients ate, a new report said. From there, the bristles ...
... used by cancer and transplant patients, and there are hints that it ... it also comes with a downside: rapamycin leads to diabetes in as ... Now, researchers reporting in the April Cell Metabolism , a Cell ... insulin signal off in muscle, to prevent muscle cells from taking blood ...
... TUESDAY, April 3 (HealthDay News) -- A vaccination may help ... small new study reports. The prognosis for many ... is the only effective treatment, although there has been hope ... The results of the new study, which included 27 children ...
... blood vessels earlier than previously thought, and these structural ... the development of high blood pressure. These findings in ... of Virginia School of Medicine in the US, are ... Research . With age, increasing weight and metabolic ...
... Women having children at older ages and the growing availability ... the birth of twins: In 2009, one in every 30 ... with one in every 53 in 1980. The findings, ... the 14th Congress of the International Society of Twin Studies ...
... is a disconnect between the number of cancer patients estimated to ... for orthopedic care each year, states an article in the ... 140 000 new cases of cancer diagnosed in Canada each year ... are referred to orthopedic services even though they could benefit in ...
Cached Medicine News:Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 2Health News:BBQ Danger: Wires From Grill Cleaners Swallowed in Food 3Health News:How a cancer drug leads to diabetes 2Health News:Study Suggests Vaccine May Help Kids With Brain Cancer 2Health News:Arteries under pressure early on 2Health News:Seeing double: 1 in 30 babies born in US is a twin 2
The VISULAS 532s combines ease of use, efficiency and safety to provide ophthalmologists with an overall system sharply focused on their requirements. ,The VISULAS 532s is a laser of many talent...
Two point fixation, tips separated by 13 mm. Each tip has 0.12 mm, 1 x 2 teeth. Flat serrated handle with polished finish. Without lock....
... A simple, effective method for determining ... Provides reliable data which can be applied ... problems. The set consists of four trays ... reference caps that have incremental hue variation ...
... D15 test evaluation has a choice ... caps with automatic creation 'horse-shoe' diagrams, ... deficiency analysis, calculation of color confusion ... eye selection (OD, OS, OU) and ...
Medicine Products: